Long-Term Safety and Efficacy of Dupilumab Treatment in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis
Paediatr Drugs. 2026 Apr 2. doi: 10.1007/s40272-026-00747-4. Online ahead of print. ABSTRACT BACKGROUND: Infants and young children with severe atopic dermatitis (AD) have a high …